LOS ANGELES — Today’s volatile environment is impacting the markets, but innovation in ophthalmology will drive the sector and lead to increased value, a JP Morgan managing director told attendees at SightLine.
“Volatility is the theme of the market in 2025,” Mike Connor said, and the resulting uncertainty is affecting private and public financing.
“We are in a down cycle, but we will get through it,” he said. “The driver of that will be innovation. It will be the inventors, the founders, the operators, investors, physicians, surgeons — everyone